New Advances in Pulmonary Fibrosis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 28 February 2026
Special Issue Editor
Interests: pulmonary fibrosis; familial pulmonary fibrosis; induced pluripotent stem cell-derived organoid models; telomere biology; sex hormones; alveolar epithelial type 2 cells
Special Issue Information
Dear Colleagues,
We are delighted to invite you to submit an article to this Special Issue on “New Advances in Pulmonary Fibrosis”.
Pulmonary fibrosis represents a group of debilitating interstitial lung diseases marked by progressive scarring of the lung parenchyma, with rising global incidence and limited treatment options. Despite the availability of FDA-approved antifibrotic drugs, pirfenidone and nintedanib, morbidity and mortality remain high. As a result, there is an urgent need for improved diagnostic tools and novel treatments with better efficacy and safety profiles.
Recent advances in diagnostics include transbronchial cryobiopsy and genomic classifier testing, which offer less invasive approaches with favourable safety and accuracy. Artificial intelligence-assisted imaging is also emerging as a promising tool for early detection, though challenges in standardization persist. On the therapeutic front, new agents targeting alternative pathways are in development. Notably, nerandomilast, a selective PDE4B inhibitor, has shown encouraging results in early trials, both as monotherapy and in combination with current antifibrotics.
This Special Issue aims to bring together cutting-edge research and expert reviews, highlighting the latest progress in pulmonary fibrosis research, from pathobiology, evolving diagnostic methods to innovative therapeutic strategies and personalized medicine approaches to provide a comprehensive overview of the evolving landscape of pulmonary fibrosis and its implications for both clinical practice and translational research.
Dr. Mari Ozaki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary fibrosis
- interstitial lung disease
- antifibrotic therapy
- precision medicine
- imaging diagnostics
- novel therapeutics
- pathobiology
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
